All Neuroinflammatory conditions articles
-
NewsExisting drug could target neuroinflammation across multiple brain disorders
Researchers at the University of Birmingham have identified the P2X7 receptor as a key driver of neuroinflammation in human brain tissue, raising the prospect of repurposing existing therapies to treat various brain conditions.
-
ArticleHow GPCR-targeting therapies are advancing the fight against inflammatory disease
Discover how Domain Therapeutics is using its deep knowledge of GPCR biology to create novel therapeutics with the potential to combat inflammatory diseases such as atopic dermatitis, IBD and arthritis.